Pharming Group - Dividend History | PHGUF
Historical dividend payout and yield for Pharming Group (PHGUF) since 1971. The current TTM dividend payout for Pharming Group (PHGUF) as of December 31, 1969 is $0.00. The current dividend yield for Pharming Group as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.620B |
$0.245B |
|
Pharming Group NV develops innovative therapeutics for the treatment of genetic disorders, specialty products for surgical indications and nutritional products. The advanced technologies of the Company include innovative and validated platforms for the production of protein therapeutics, technology and processes for the purification and formulation of its products. Its primary product Ruconest (R) is a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with hereditary angioedema in the European Union countries, Norway, Iceland and Liechtenstein. Pharming Group NV is headquartered in Leiden, the Netherlands.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
